0000899243-23-003615.txt : 20230202 0000899243-23-003615.hdr.sgml : 20230202 20230202183314 ACCESSION NUMBER: 0000899243-23-003615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sommadossi Jean-Pierre CENTRAL INDEX KEY: 0001296995 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 23582849 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-31 0 0001593899 Atea Pharmaceuticals, Inc. AVIR 0001296995 Sommadossi Jean-Pierre 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 1 1 0 0 President, CEO, and Chairman Restricted Stock Units 2023-01-31 4 A 0 520400 0.00 A Common Stock 520400 520400 D Stock Option (Right to Buy) 4.63 2023-01-31 4 A 0 728600 0.00 A 2033-01-30 Common Stock 728600 728600 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. /s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi 2023-02-02